Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
RANDOMIZED TRIAL OF IRINOTECAN AND CETUXIMAB (IC) VERSUS IRINOTECAN, CETUXIMAB AND RAMUCIRUMAB (ICR) AS 2ND LINE THERAPY OF ADVANCED COLORECTAL CANCER (CRC) FOLLOWING OXALIPLATIN AND BEVACIZUMB BASED THERAPY: RESULT OF E7208
12 března, 2021 4:23 pmMeeting: 2018 ASCO Annual Meeting Track: Gastrointestinal (Colorectal) Cancer Abstract number: 3504 Citation: J Clin Oncol 36,...
LONG-TERM RESULTS OF THE ADORE TRIAL: ADJUVANT OXALIPLATIN, LEUCOVORIN, AND 5-FLUOROURACIL (FOLFOX) VERSUS 5-FLUOROURACIL AND LEUCOVORIN (FL) AFTER PREOPERATIVE CHEMORADIOTHERAPY AND SURGERY FOR LOCALLY ADVANCED RECTAL CANCER
12 března, 2021 4:13 pmMeeting: 2018 ASCO Annual Meeting Track: Gastrointestinal (Colorectal) Cancer Abstract number: 3501 Citation: J Clin Oncol 36,...
HIPEC PROVIDES NO ADDITIONAL BENEFIT TO COMPLETE RESECTION IN COLORECTAL PERITONEAL CARCINOMATOSIS
12 března, 2021 4:06 pmJune 4, 2018 The addition of oxaliplatin hyperthermic peritoneal chemotherapy (HIPEC) combined with cytoreductive surgery in patients with colorectal...
Novinky z ASCO 2018 – kolorektální karcinom
12 března, 2021 4:00 pmNejvětšího celosvětového onkologického kongresu, pořádaného již tradičně v obřím kongresovém centru McCormick Place ve městě Chicago (Illinois, USA), se letos...
IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (FL) IN THE RANDOMIZED PHASE III GALLIUM STUDY: ANALYSIS BY CHEMOTHERAPY REGIMEN
4 března, 2021 6:45 pmAuthor(s): Wolfgang Hiddemann, Anna Maria Barbui, Miguel Angel Canales Albendea, Paul K Cannell, Graham P Collins, Jan Dürig, Roswitha Forstpointner,...
PATIENTS WITH IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE SHOW SIMILAR SURVIVAL PATTERNS AS LOW RISK MDS PATIENTS
4 března, 2021 6:43 pmAuthor(s): Jakob Werner Hansen, Maj Westman, Andreas Due Orskov, et al. Abstract: S 486 Session topic: 10. Myelodysplastic...
A PHASE IB STUDY EVALUATING THE SAFETY AND CLINICAL ACTIVITY OF ATEZOLIZUMAB ALONE AND IN COMBINATION WITH AZACITIDINE IN PATIENTS WITH RELAPSED OR REFRACTORY MYELODYSPLASTIC SYNDROMES
4 března, 2021 6:40 pmAuthor(s): Aaron T. Gerds, Bart L. Scott, Peter Greenberg, et al. Abstract: P 662 Session topic: 10. Myelodysplastic...
DIFFERENTIAL DIAGNOSIS BETWEEN MYELODYSPLASTIC SYNDROMES AND NON-CLONAL CYTOPENIAS BY FLOW CYTOMETRY ANALYSIS USING A MYELOID MATURATION DATABASE
4 března, 2021 6:38 pmAuthor(s): M Teresa Cedena, Fátima Mirás, Rosa M Ayala, et al. Abstract: P 661 Session topic: 9. Myelodysplastic...
UPDATED RESULTS FROM PHASE 2 STUDY OF GUADECITABINE FOR PATIENTS WITH UNTREATED INT-2/HIGH RISK MYELODYSPLASTIC SYNDROMES OR CHRONIC MYELOMONOCYTIC LEUKEMIA
4 března, 2021 6:36 pmAuthor(s): Guillermo Montalban-Bravo, Prithviraj Bose, Yesid Alvarado, et al. Abstract: P 315 Session topic: 10. Myelodysplastic syndromes –...
Kongres Evropské hematologické společnosti
4 března, 2021 6:34 pmV rámci každoročního kongresu Evropské hematologické společnosti, jež se konal ve dnech 22. až 25. června 2017 v Madridu (Španělsko), bylo prezentováno několik...